Friday Letter 22/03/2019

Friday 22nd March 2019

Help Us Help You Pharmacy Campaign.

The first 2019/2020 mandatory pharmacy campaign, ‘Help us help you: before it gets worse’ will end next Sunday.

We hope you have all been actively participating for a successful Pharmacy campaign, please be reminded of the advert below and the LPC page for more information.

NHS England campaign video:,

Health campaign page:


DSP Toolkit (Information governance) deadline next week

The deadline for the Data Security and Protection (DSP) Toolkit for 2018/19 is next week, Sunday 31st March 2019. This toolkit replaces the Information Governance (IG) Toolkit from previous years.

If you have not already done so, please begin working through this to ensure you meet next weeks deadline

DPS Toolkit:

PSNC DSP toolkit FAQs:


Update- March 2019 Price concessions

The following price concessions have been granted for March 2019.

Click here to view


Controlled Drugs & EPS – Roll Out

Please see the following letter regarding the national roll out for Controlled Drugs in EPS. All pharmacists should read this through in full, ensure they understand the letter’s content and take the appropriate action to prepare for the roll out.

Once read, please also make sure all pharmacy staff are made aware of the upcoming changes.


Diabetes Prevention & April Campaigns

The Public Health Campaign ‘Diabetes Prevention Week’ begins on 1st April 2019. This campaign aims to raise awareness of Type 2 diabetes, focusing on prevention by highlighting information of at-risk groups, and how lifestyle changes can decrease the chances of developing the condition.

If you wish to get involved in this campaign, please order your materials from the PHE resource centre.

The toolkit includes the following:

  • Leaflets
  • Posters
  • Bunting
  • Sticker sheet
  • 2 waist tape measures
  • Campaign letter

The campaign resource centre also has digital campaign resources that can be used to promote the campaign on screens and via social media.

Click here for the PHE campaign resource centre

April Campaigns 2019

There are several health campaigns and awareness days that your pharmacy teams can get involved in throughout April.

Click here for more information:


DMIRS Extension

The DMIRS pilot (set to end 31st March 2019) is being extended in four areas, including London.

Funding will be provided through the NHS England Pharmacy Integration Fund to continue the DMIRS pilots in all 4 areas (London, Devon, North East and East Midlands) to the end of June 2019.


Prescription charge increase

Please be reminded that from 1st April 2019, the prescription charge will rise to £9.00, 20p more than the current £8.80.

The price of prescription pre-payment certificates (PPCs) will remain the name for another year, a three-month PPC at £29.10 and a 12-month PPC at £104.00.


Class 2 Medicines Alert recall: Accord Healthcare Limited – Losartan Potassium 50mg Film-coated Tablets, PL 20075/0022 and Losartan Potassium 100mg Film-coated Tablets, PL 20075/0023

Published 21st March 2019

There is the potential for products containing Losartan Potassium that are contaminated with a nitrosamine, N-nitroso-N-methylamino butyric acid (NMBA).

The following batches of Losartan Potassium containing products from Accord Healthcare Limited are being recalled as a result.

Losartan Potassium 50mg Film-coated Tablets, PL 20075/0022

Batch number Expiry date Pack size Date of first distribution
PT04882 Nov 2019 1 x 28 28 March 2018

Losartan Potassium 100mg Film-coated Tablets, PL 20075/0023

Batch number Expiry date Pack size Date of first distribution
PT02738 June 2019 1 x 28 27 Feb 2017
GX0135 Aug 2020 1 x 28 7 Feb 2019

MHRA have given the following action points for health professionals and wholesalers. Please read the full drug alert take the appropriate action immediately.

MHRA Action:

  • Stop supplying the batches listed above immediately. Quarantine all remaining stock and return it to your supplier using your supplier’s approved process.
  • If you receive queries about this issue from patients, advise them to continue taking their medication as the health risk of discontinuing the medicine is higher than the potential risk presented by the contaminant. A treatment review is not necessary until the next routine appointment.
  • We do not anticipate any shortages of Losartan Potassium containing products. In case of local supply issues, patients should be advised to speak to their doctor to discuss alternative treatments.

Click here for the full alert


Medical Device Alert: ‘enFlow® IV fluid and blood warmer – risk of unsafe levels of aluminium leaching from the device – updated safety advice from manufacturer’

The above alert has been issued, please read through the full report and take the appropriate action as necessary.

Actions should be underway by 26th March for completion by 10th April 2019.


Manufactured by Vyaire – Cartridges with an aluminium warming plate in the fluid pathway can lead to an IV infusion containing aluminium above currently recommended safe levels.

Description Manufacturers reference NHS Supply Chain reference
Blood and fluid warming unit 980105VS FSB1143
Blood and fluid warming disposable cartridges 980200EU FSB1143
Blood and fluid warming disposable cartridges with extension (30) 980202EU FSB1143

See full alert on the website

This MDA is updated safety advice from manufacturer and replaces the previous advice (MDA/2019/015).


PCSE March 2019 e-bulletin

The March 2019 edition of the e-bulletin from PCSE has been published. This bulletin includes:

  • How do I opt in or out of receiving the monthly hard copy drug tariff?
  • Top tips for completing Market Entry applications
  • Submitting enquiries to the Market Entry team
  • New online form to replace paper applications for Market Entry

The latest Pharmacy bulletin can be viewed using the following link:


Leave a Reply